JD Health International Inc.

SEHK:6618 Stock Report

Market Cap: HK$189.8b

JD Health International Future Growth

Future criteria checks 3/6

JD Health International is forecast to grow earnings and revenue by 14.6% and 13% per annum respectively. EPS is expected to grow by 13.7% per annum. Return on equity is forecast to be 10% in 3 years.

Key information

14.6%

Earnings growth rate

13.66%

EPS growth rate

Consumer Retailing earnings growth24.2%
Revenue growth rate13.0%
Future return on equity9.98%
Analyst coverage

Good

Last updated08 Dec 2025

Recent future growth updates

JD Health International Inc. Just Recorded A 32% EPS Beat: Here's What Analysts Are Forecasting Next

Mar 09
JD Health International Inc. Just Recorded A 32% EPS Beat: Here's What Analysts Are Forecasting Next

Recent updates

Be Wary Of JD Health International (HKG:6618) And Its Returns On Capital

Dec 08
Be Wary Of JD Health International (HKG:6618) And Its Returns On Capital

Is JD Health International Inc. (HKG:6618) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 11
Is JD Health International Inc. (HKG:6618) Expensive For A Reason? A Look At Its Intrinsic Value

With EPS Growth And More, JD Health International (HKG:6618) Makes An Interesting Case

Oct 28
With EPS Growth And More, JD Health International (HKG:6618) Makes An Interesting Case

Is Now The Time To Look At Buying JD Health International Inc. (HKG:6618)?

Sep 22
Is Now The Time To Look At Buying JD Health International Inc. (HKG:6618)?

JD Health International Inc.'s (HKG:6618) Shareholders Might Be Looking For Exit

Aug 06
JD Health International Inc.'s (HKG:6618) Shareholders Might Be Looking For Exit

JD Health International (HKG:6618) Could Be Struggling To Allocate Capital

Jul 07
JD Health International (HKG:6618) Could Be Struggling To Allocate Capital

Is There Now An Opportunity In JD Health International Inc. (HKG:6618)?

Jun 22
Is There Now An Opportunity In JD Health International Inc. (HKG:6618)?

Is Now The Time To Put JD Health International (HKG:6618) On Your Watchlist?

May 22
Is Now The Time To Put JD Health International (HKG:6618) On Your Watchlist?

What JD Health International Inc.'s (HKG:6618) 37% Share Price Gain Is Not Telling You

May 07
What JD Health International Inc.'s (HKG:6618) 37% Share Price Gain Is Not Telling You

JD Health International (HKG:6618) Could Be Struggling To Allocate Capital

Mar 24
JD Health International (HKG:6618) Could Be Struggling To Allocate Capital
User avatar

AI Integration With Jingyi Qianxun Will Improve Efficiency In Healthcare Services

Technological innovations and strategic partnerships aim to enhance customer experience, expand market share, and increase direct sales and margins.

JD Health International Inc. Just Recorded A 32% EPS Beat: Here's What Analysts Are Forecasting Next

Mar 09
JD Health International Inc. Just Recorded A 32% EPS Beat: Here's What Analysts Are Forecasting Next

Calculating The Fair Value Of JD Health International Inc. (HKG:6618)

Feb 26
Calculating The Fair Value Of JD Health International Inc. (HKG:6618)

Why Investors Shouldn't Be Surprised By JD Health International Inc.'s (HKG:6618) 27% Share Price Surge

Feb 10
Why Investors Shouldn't Be Surprised By JD Health International Inc.'s (HKG:6618) 27% Share Price Surge

Should You Be Adding JD Health International (HKG:6618) To Your Watchlist Today?

Jan 24
Should You Be Adding JD Health International (HKG:6618) To Your Watchlist Today?

Should You Think About Buying JD Health International Inc. (HKG:6618) Now?

Jan 07
Should You Think About Buying JD Health International Inc. (HKG:6618) Now?

JD Health International's (HKG:6618) Returns On Capital Not Reflecting Well On The Business

Dec 17
JD Health International's (HKG:6618) Returns On Capital Not Reflecting Well On The Business

Earnings and Revenue Growth Forecasts

SEHK:6618 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202794,8596,9429,4147,74318
12/31/202682,6265,7217,9616,54120
12/31/202571,1724,9106,2575,98719
6/30/202565,1064,7218,2858,347N/A
3/31/202561,6334,4416,2906,340N/A
12/31/202458,1604,1624,2944,332N/A
9/30/202456,4623,3905,3655,400N/A
6/30/202454,7642,6186,4326,467N/A
3/31/202454,1472,3805,4885,536N/A
12/31/202353,5302,1424,5444,605N/A
9/30/202353,5761,9303,1354,311N/A
6/30/202353,6211,7181,7264,017N/A
3/31/202350,1791,0492,6794,961N/A
12/31/202246,7363803,6325,905N/A
9/30/202242,003-73,4404,829N/A
6/30/202237,270-3953,2493,753N/A
3/31/202233,976-7343,0853,592N/A
12/31/202130,682-1,0742,9213,431N/A
9/30/202127,463-6,7024,0684,352N/A
6/30/202124,243-12,3315,2165,274N/A
3/31/202121,813-14,7834,4394,487N/A
12/31/202019,383-17,2343,6623,699N/A
9/30/202017,007-11,9011,9802,004N/A
6/30/202014,631-6,567298309N/A
3/31/202012,737-3,769351359N/A
12/31/201910,842-972404409N/A
12/31/20188,169215N/A187N/A
12/31/20175,553179N/A36N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 6618's forecast earnings growth (14.6% per year) is above the savings rate (2.8%).

Earnings vs Market: 6618's earnings (14.6% per year) are forecast to grow faster than the Hong Kong market (12.1% per year).

High Growth Earnings: 6618's earnings are forecast to grow, but not significantly.

Revenue vs Market: 6618's revenue (13% per year) is forecast to grow faster than the Hong Kong market (8.5% per year).

High Growth Revenue: 6618's revenue (13% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 6618's Return on Equity is forecast to be low in 3 years time (10%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/10 09:27
End of Day Share Price 2025/12/10 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

JD Health International Inc. is covered by 32 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xiaomeng ZhuangBofA Global Research
Shun Kei LawCCB International Securities Limited
Xipeng FengChina International Capital Corporation Limited